|Articles|March 24, 2015

Genetic Discovery May Offer New Avenue of Attack Against Schistosomiasis

 Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this debilitating disease.

Researchers have discovered a group of genes in this snail, Biomphalaria glabrata, that conveys resistance to the parasite that causes schistosomiasis. Photo courtesy of Oregon State University

Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this debilitating disease.

Schistosomiasis infects more than 200 million people in more than 70 countries, and is most common in areas with poor sanitation. It can cause chronic, lifelong disability, beginning with gastrointestinal problems and sometimes leading to liver damage, kidney failure, infertility and bladder cancer.

Schistosomisasis, which is native to Africa but has now spread around the world, has been called a neglected global pandemic. Its impact on human health rivals that of malaria.

However, the circular transmission of this complex disease depends upon spending some time as an infection in aquatic snails, where the number of parasites is greatly magnified. Snails may therefore offer a key opportunity to break the cycle of transmission.

The findings about this genetic discovery were just published in PLOS Genetics, by researchers from OSU and the Universite de Perpignan Via Domitia in France. The work was supported by the National Institutes of Health.

"We've found a new class of previously unknown genes that appear to control the ability to resist schistosomes," says Michael Blouin, a professor of integrative biology in the OSU College of Science. "It was found that a dominant genetic allele in this region conveys an eight-fold decrease in the risk of schistosomiasis infection.

"These genes are the type that, in other animal species, help to recognize pathogens and trigger an immune response," Blouin says. "This is important new information. With further research we'll learn more about the exact genetics and molecules that are involved as the parasite interacts with the host."

There are two possible applications of these results that could be pursued in an effort to treat or control this disease, the researchers said. One would be development of new drugs, which could be important - right now only a single medication, praziquantel, exists to help treat the disease. With its increasingly widespread use, resistance to that drug is possible.

Alternatively, researchers might attempt to insert these parasite-resistant genes into the species of snails that most commonly transmit schistosomiasis.

"There are ways to drive new genes into a population," says Jacob Tennessen, an OSU postdoctoral research associate and lead author on this study.

This is already being tried for some other diseases, the scientists noted, such as in mosquitos that transmit malaria. Modifying snail populations to be resistant is currently not practical, they said, but identifying new genes that control resistance to the parasite is a critical first step.

Source: Oregon State University


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.